Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients

Lu He(Hubei University of Medicine), Jian Hong(Seoul National University), Xinke Zhou(Xinjiang Medical University), Yunqiang Tang(Guangzhou Medical University), Chen Qu(Tongji University)
Medical Oncology
August 30, 2013
Cited by 50


Related Papers